Anti-carbamylated protein antibodies in the pre-symptomatic phase of rheumatoid arthritis, their relationship with multiple anti-citrulline peptide antibodies and association with radiological damage.
about
Therapeutic implications of autoantibodies in rheumatoid arthritisPosttranslational Modifications and the Immunogenicity of BiotherapeuticsBiomarkers to guide clinical therapeutics in rheumatology?Association between antibodies to carbamylated proteins and subclinical atherosclerosis in rheumatoid arthritis patients.Meta-Analysis: Diagnostic Accuracy of Anti-Carbamylated Protein Antibody for Rheumatoid Arthritis.Anti-Carbamylated Protein Antibodies as a Reproducible Independent Type of Rheumatoid Arthritis Autoantibodies.Rheumatoid factor isotypes in relation to antibodies against citrullinated peptides and carbamylated proteins before the onset of rheumatoid arthritis.Predictive factors of radiological progression after 2 years of remission-steered treatment in early arthritis patients: a post hoc analysis of the IMPROVED study.Anticarbamylated protein antibodies are associated with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the Norfolk Arthritis Register.Antibodies against carbamylated proteins are present in primary Sjögren's syndrome and are associated with disease severity.The role for neutrophil extracellular traps in cystic fibrosis autoimmunity.Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseasesAntibodies against carbamylated proteins and cyclic citrullinated peptides in systemic lupus erythematosus: results from two well-defined European cohorts.Anti-carbamylated protein antibodies presence in early arthritis with a poorer clinical and radiological outcome: data from the French ESPOIR cohort.Arthritis models: usefulness and interpretation.Smoking is associated with the concurrent presence of multiple autoantibodies in rheumatoid arthritis rather than with anti-citrullinated protein antibodies per se: a multicenter cohort study.Antibodies to carbamylated α-enolase epitopes in rheumatoid arthritis also bind citrullinated epitopes and are largely indistinct from anti-citrullinated protein antibodies.Anticitrullinated protein antibodies and rheumatoid factor are associated with increased mortality but with different causes of death in patients with rheumatoid arthritis: a longitudinal study in three European cohorts.Carbamylation of vimentin is inducible by smoking and represents an independent autoantigen in rheumatoid arthritis.The isotype and IgG subclass distribution of anti-carbamylated protein antibodies in rheumatoid arthritis patients.Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients.Anti-carbamylated protein antibodies in rheumatoid arthritis patients and their association with rheumatoid factorThe specificity of anti-carbamylated protein antibodies for rheumatoid arthritis in a setting of early arthritis.Role of Anti-Carbamylated Protein Antibodies Compared to Anti-Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First-Degree Relatives, and Healthy Controls.Anti-carbamylated protein antibodies precede disease onset in monkeys with collagen-induced arthritis.An increased concentration of receptor activator of nuclear factor kappa-B ligand pre-dates the onset of rheumatoid arthritis.Bone Loss in Rheumatoid Arthritis: Basic Mechanisms and Clinical Implications.Baseline autoantibody profile in rheumatoid arthritis is associated with early treatment response but not long-term outcomes.Brief Report: Anti-Carbamylated Protein Antibodies in Rheumatoid Arthritis Patients Are Reactive With Specific Epitopes of the Human Fibrinogen β-Chain.Anti-LL37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsAThe association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factorAssociation of high titers of anti-carbamylated protein antibodies with decreased bone mineral density in early arthritis patientsSurvivin Measurement improves Clinical Prediction of Transition From Arthralgia to RA-Biomarkers to Improve Clinical Sensitivity of Transition From Arthralgia to RA
P2860
Q26744033-2905CE91-92ED-428B-83B5-6DC7C76290EFQ26748614-1CCE515A-692D-43E7-B16B-19F637851073Q28080053-4E67B6A5-F990-4D59-87BF-EE14B79967C2Q33730073-37E8DD95-E41F-47AC-B991-064F78DC4422Q36082681-925EF89E-22F6-4CFF-891C-102D7F3D94DCQ36107157-DEF60898-8080-4A2B-8D84-9C2D99FF1FDAQ36565997-A975AF46-6780-4F63-AA5A-E5EE69DC96DFQ36603271-48EC5375-937F-45AC-8AF5-28308429C38DQ36968730-7AEEDFD4-905D-426D-9AF9-968078C0E58EQ37156391-5D9E70C1-F0C8-40F5-8C00-90A60846407AQ37351609-05CDC452-8F59-441D-B187-23AA75B307FFQ37442781-FC7DC368-B4E2-4251-8DBC-61C3C4A503D1Q37470470-0853F7F4-ED87-4B32-A2AE-713BD068F16AQ38602504-773595EA-0F4D-47A3-A544-97C6221F8775Q38872112-715AAE49-9670-429E-8C7C-94DD7A5AB4B4Q39139958-B21BF4C7-4960-4A44-A6CF-CEB2994D1D06Q39794799-393857B9-1299-4FC6-93F4-F9AA75E5B240Q40117130-69F8615E-1D4E-4055-BE12-C0B1299CD827Q41146137-76617A06-B992-4C2B-8DA8-6F7A92D13BF3Q41431357-8C5FDAC4-D598-4AEE-8CF0-80154E95A2EFQ41697121-4D1E14E0-1214-4217-B826-A8DB504F4C4AQ42643869-7CBDEE24-82C3-413E-9C34-3D641FEFD04AQ43158822-12997578-4317-47FD-8B1E-475EF6A7435BQ46640361-17B6F1F4-5642-4D82-B183-FD7866115598Q47129849-62F97415-1855-42BC-95C9-572313ACFC1EQ47175280-D5B74D31-4D67-4AC4-B076-205E5C8D2E07Q47800990-C56ECBFB-3203-40F6-9C08-52B813692484Q50326875-1B2173E1-22EA-4689-9C45-CF12A47B10ECQ51098357-F70A11F9-36EF-415C-8C2F-2125BF96F1DEQ57112378-E6564182-1567-4CDD-BA51-11B7F5C01447Q58234648-8AA7C90A-7C02-4026-AF27-3C34181DEACAQ58771663-4C1CC494-C351-4321-BBB2-26211D920C60Q58803456-8E7211B0-A817-4393-86B4-6EA94533EA8A
P2860
Anti-carbamylated protein antibodies in the pre-symptomatic phase of rheumatoid arthritis, their relationship with multiple anti-citrulline peptide antibodies and association with radiological damage.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Anti-carbamylated protein anti ...... tion with radiological damage.
@ast
Anti-carbamylated protein anti ...... tion with radiological damage.
@en
type
label
Anti-carbamylated protein anti ...... tion with radiological damage.
@ast
Anti-carbamylated protein anti ...... tion with radiological damage.
@en
prefLabel
Anti-carbamylated protein anti ...... tion with radiological damage.
@ast
Anti-carbamylated protein anti ...... tion with radiological damage.
@en
P2093
P2860
P50
P1476
Anti-carbamylated protein anti ...... tion with radiological damage.
@en
P2093
Johan Rönnelid
Lars Klareskog
Marije K Verheul
Rikard Holmdahl
P2860
P2888
P356
10.1186/S13075-015-0536-2
P577
2015-02-07T00:00:00Z
P5875
P6179
1007067965